Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media
Cancer Biology Faculty

Faculty, Lecturers and Instructors

Many DKFZ laboratories are incorporated into our innovative Major "Cancer Biology" Program. This allows the students to experience cutting edge science and to interact with internationally leading scientists at a very early stage of their career.

 

The lists of lecturers and instructors actively involved in the Major Cancer Biology study program are arranged according to their affiliation with the various Research Divisions and Groups of the six DKFZ Research Programs (Forschungsschwerpunkte):

 

Dr. Julieta ALFONSO, Division of Clinical Neurobiology (A230/Junior Group A231) E-mail

Dr. Elisenda ALSINA SANCHIS, Division of Vascular Signaling and Cancer (A270E-mail

Prof. Dr. Peter ANGEL, Division of Signal Transduction and Growth Control (A100) E-mail

Prof. Dr. Hellmut AUGUSTIN, Division of Vascular Oncology and Metastasis (A190) E-mail

Juniorprof. Dr. Lazaro CENTANIN, Heidelberg University Centre of Organismal Studies (COS) E-mail

Dr. Vitor COUTINHO CARNEIRO, Division of Epigenetics (A130) E-mail

Prof. Dr. Tobias DICK, Division of Redox Regulation (A160) E-mail

Dr. Marieke ESSERS, Division of Inflammatory Stress in Stem Cells (A011) E-mail

Prof. Dr. Michaela FRYE, Division of Mechanisms Regulating Gene Expression (A350) E-mail

Dr. Sarah GEIGER, Division of Inflammatory Stress in Stem Cells (A011) E-mail

Prof. Dr. Ilse HOFMANN, Division of Vascular Oncology and Metastasis (A190E-mail

Dr. Rene-Filip JACKSTANDT, Junior Research Group Cancer Progression and Metastasis (A013) and HI-STEM E-mail

Dr. Susanne KLEBER, Division of Molecular Neurobiology (A290) E-mail

Dr. Paraskevi KRITSILIGKOU, Division of Redox Regulation (A160) E-mail

Dr. Hai-Kun LIU, Division of Molecular Neurogenetics (A240) E-mail

Prof. Dr. Frank LYKO, Division of Epigenetics (A130) E-mail

Dr. Moritz MALL, Junior Research Group Cell Fate Engineering and Disease Modeling (A340) E-mail

Prof. Dr. Ana MARTIN-VILLALBA, Division of Molecular Neurobiology (A290) E-mail

Dr. Michael MILSOM, Division of Experimental Hematology (A012) E-mail

PD Dr. Karin MÜLLER-DECKER, Core Facility Tumor Models (W420), E-mail

Dr. Wilhem PALM, DKFZ Junior Research Group Cell Signaling and Metabolism (A330), E-mail

Prof. Dr. Almut SCHULZE, Division of Tumour Metabolism and Microenvironment (A410E-mail

Prof. Dr. Andreas TRUMPP, Division of Stem Cells and Cancer (A010) and HI-STEM E-mail

Prof. Dr. Viktor UMANSKY, Clinical Cooperation Unit for Dermato-Oncology (A370) E-mail

 

Dr. Ali BAKR, Division of Cancer Epigenomics (B370) E-mail

Dr. Ana BANITO, Junior Research Group Soft-Tissue Sarcoma (B380) and Hopp-Kindertumorzentrum KiTZ E-mail

Prof. Dr. Michael BOUTROS, Division Signaling and Functional Genomics (B110) E-mail

Prof. Dr. Benedikt BRORS, Division of Applied Bioinformatics (B330) E-mail

Dr. Maïwen CAUDRON-HERGER, Division of RNA Biology and Cancer (B150) E-mail

Dr. Priya CHUDASAMA, Emmy Noether Junior Research Group Precision Sarcoma Research (B390) E-mail

Prof. Dr. Sven DIEDERICHS, Division of RNA Biology and Cancer (B150) E-mail

Dr. Sebastian DIETER, Research Group Translational Functional Cancer Genomics (B280) E-mail

Dr. Cihan ERKUT, Division of Applied Functional Genomics (B290E-mail

Dr. Aurélie ERNST, DKFZ Junior Group Genome Instability in Tumors (B420) E-mail

Prof. Dr. Stefan FRÖHLING, Division of Translational Oncology (B340) and NCT E-mail

Dr. Clarissa GERHÄUSER, Division of Cancer Epigenomics (B370) E-mail

Dr. Violaine GOIDTS, DKFZ Junior Group Brain Tumor Translational Targets (B067) E-mail

Dr. Ashish GOYAL, Division of Cancer Epigenomics (B370) E-mail

Dr. Mark HARTMANN, Division of Translational Medical Oncology (B340) and NCT Section Translational Cancer Epigenomics E-mail

Dr. Florian HEIGWER, Division Signaling and Functional Genomics (B110) E-mail

Dr. Dominic HELM, GPCF Genomics and Proteomics Core Facility - Protein Analysis Unit (W120) E-mail

PD Dr. Sabine KLAUCK, Division of Cancer Genome Research (B063) E-mail

Prof. Dr. Ursula KLINGMÜLLER, Division of Systems Biology of Signal Transduction (B200)

Dr. Cindy KÖRNER, Division of Molecular Genome Analysis (B050) E-mail

Prof. Dr. Jeroen KRIJGSVELD, Division of Proteomics of Stem Cells and Cancer (B230) E-mail

PD Dr. Stephanie LAUFS, Core Area Translational Medical Oncology at NCT E-mail

Prof. Dr. Peter LICHTER, Division of Molecular Genetics (B060) E-mail

PD Dr. Daniel LIPKA, Division of Translational Medical Oncology (B340) and NCT Section Translational Cancer Epigenomics E-mail

Dr. Maria LLAMAZARES PRADA, Division of Cancer Epigenomics (B370) E-mail

Dr. Fabricio LOAYZA-PUCH, Junior Research Group Translational Control and Metabolism (B250) E-mail

Dr. Pavlo LUTSIK, Division of Cancer Epigenomics (B370) E-mail

Prof. Dr. Duncan ODOM, Division of Regulatory Genomics and Cancer Evolution (B270) E-mail

Dr. Christiane OPITZ, DKFZ Junior Group Brain Cancer Metabolism (B350) E-mail

Prof. Dr. Stefan PFISTER, Division of Pediatric Neurooncology (B062) E-mail

Prof. Dr. Christoph PLASS, Division of Cancer Epigenomics (B370) E-mail

Dr. Fillip PORT, Division Signaling and Functional Genomics (B110) E-mail

PD Dr. Stefan PUSCH, Clinical Cooperation Unit Neuropathology (B300) E-mail

Dr. Marcel SCHILLING, Division of Systems Biology of Signal Transduction (B200) E-mail

Dr. Peter SCHMEZER, Division of Cancer Epigenomics (B370) E-mail

Prof. Dr. Claudia SCHOLL, Division of Applied Functional Genomics (B290E-mail

Dr. Martina SEIFFERT, Division of Molecular Genetics (B060) E-mail

Prof. Dr. Rocio SOTILLO, Division of Molecular Thoracic Oncology (B220) E-mail

Prof. Dr. Aurelio TELEMAN, Division of Signal Transduction in Cancer and Metabolism (B140) E-mail

Dr. Sevin TURCAN, Clinical Cooperation Unit Neurooncology (B320) and Max-Eder Research Group Neuro-Oncology of Lower Grade Gliomas, Heidelberg University Hospital E-mail

Dr. Johanna WAGNER, Division of Translational Oncology (B340) and NCT  E-mail

Dr. Dieter WEICHENHAN, Division of Cancer Epigenomics (B370) E-mail

PD Dr. Frank WESTERMANN, Division of Neuroblastoma Genomics (B087) E-mail

Prof. Dr. Stefan WIEMANN, Division of Molecular Genome Analysis (B050) E-mail

Dr. Piotr ZADORA, Division of Systems Biology of Signal Transduction (B200) E-mail

 

PD Dr. Michael HOFFMEISTER, Division of Clinical Epidemiology and Aging Research (C070) E-mail

Prof. Dr. Rudolf KAAKS, Division of Cancer Epidemiology (C020) E-mail

Prof. Dr. Justo LORENZO BERMEJO, Institute of Medical Biometry and Informatics (IMBI), University Hospital Heidelberg E-mail

 

Dr. Christian BUSSE, Division of B Cell Immunology (D130) E-mail

Dr. Angel CID-ARREGUI, Clinical Cooperation Unit Applied Tumor Immunity (D120), Project Group Tumor Vaccines (D122E-mail

Dr. Branko CIROVIC, Division of Cellular Immunology (D110) E-mail

Dr. Guoliang CUI, Helmholtz University Junior Research Group T Cell Metabolism (D140E-mail

Dr. Nikolaus DIETLEIN, Division of Cellular Immunology (D110) E-mail

Prof. Dr. Stefan EICHMÜLLER, Research Group GMP and T Cell Therapy (D210) Contact Form

Dr. Thorsten FEYERABEND, Division of Cellular Immunology (D110) E-mail

Dr. Csilla KONGSAYSAK-LENGYEL, Division of Cellular Immunology (D110) E-mail

Dr. John LINDNER, BioMed X Institute, Heidelberg (Team IAA) E-mail

PD Dr. Frank MOMBURG, Clinical Cooperation Unit Applied Tumor Immunity (D120), Project Group Antigen Presentation & T/NK Cell Activation (D121E-mail

Prof. Dr. Rienk OFFRINGA, Division of Molecular Oncology of Gastrointestinal Tumors (D200) and DKFZ-Bayer Immunotherapeutics Lab E-mail

Dr. Wolfram OSEN, Research Group GMP and T Cell Therapy (D210) Contact Form

Prof. Dr. Nina PAPAVASILIOU, Division of Immune Diversity (D150) E-mail

Dr. Riccardo PECORI, Division of Immune Diversity (D150) E-mail

Dr. Thomas PLUM, Division of Cellular Immunology (D110) E-mail

Dr. Isabel POSCHKE, NCT Immune Monitoring Unit, Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology (D170) E-mail

Prof. Dr. Hans-Reimer RODEWALD, Division of Cellular Immunology (D110) E-mail

Dr. Dr. Sandrine SANDER, Junior Research Group Adaptive Immunity and Lymphoma (D180) E-mail

Dr. Patrick SCHMIDT, Clinical Cooperation Unit Applied Tumor Immunity (D120) and NCT E-mail

Dr. Erec STEBBINS, Division of Structural Biology of Infection and Immunity (D160) E-mail

Dr. Ana STOJANOVIC, Immunobiochemistry Division (UMM) E-mail

Dr. Silke UHRIG-SCHMIDT, Clinical Cooperation Unit Applied Tumor Immunity (D120) and NCT E-mail

Prof. Dr. Hedda WARDEMANN, Division of B Cell Immunology (D130) E-mail

Dr. Johan ZEELEN, Division of Structural Biology of Infection and Immunity (D160) E-mail

 

Prof. Dr. Dr. Amir ABDOLLAHI, Clinical Cooperation Unit Translational Radiation Oncology (E210) E-mail

Prof. Dr. Peter BACHERT, Research Group NMR spectroscopy and CEST imaging, Division of Medical Physics in Radiology (E020) E-mail

PD Dr. Sebastian BICKELHAUPT, Breast Imaging Research Group, Division of Radiology (E010) E-mail

Dr. Martina BENEŠOVÁ, DKFZ Bayer Junior Research Group Molecular Biology of Systemic Radiotherapy (E270) E-mail

Dr. Ivana DOKIC, Clinical Cooperation Unit Translational Radiation Oncology (E210) E-mail

Dr. Clarissa GILLMANN, Research Group MR-guided RadioTherapy (MRgRT), Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Christin GLOWA, Research Group Applied Medical Radiation Physics, Division of Medical Physics in Radiation Oncology (E040) E-mail

Prof. Dr. Jochen HESS, DKFZ Junior Group Molecular Mechanisms of Head and Neck Tumors (E221) and Heidelberg University Hospital E-mail

Dr. Paul JÄGER, Junior Research Group Interactive Machine Learning (E290) E-mail

Dr. Jürgen JENNE, Clinical Cooperation Unit Molecular Radiation Oncology (E055) E-mail

Dr. Manfred JUGOLD, Core Facility Small Animal Imaging Center (W240) E-mail

Prof. Dr. Christian KARGER, Research Group Applied Medical Radiation Physics, Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Stefan KEGEL, Division of Medical Physics in Radiology (E020) E-mail

Dr. Andreas KORZOWSKI, Research Group NMR spectroscopy and CEST imaging, Division of Medical Physics in Radiology (E020) E-mail

Dr. Tristan KUDER, Research Group Diffusion-Tensor-Imaging, Division of Medical Physics in Radiology (E020) E-mail

Dr. Jan KUNTZ, Division of X-Ray Imaging and Computed Tomography (E025) E-mail

Dr. Ina KURTH, Division of Radiooncology / Radiobiology (E220) E-mail

Prof. Dr. Mark LADD, Division of Medical Physics in Radiology (E020) E-mail

Jens LANG, Staff Uni Radiation Protection and Radiological Dosimetry (W060) E-mail

Dr. Jörg PETER, Research Group Functional and Molecular Emission Computed Tomography, Division of Medical Physics in Radiology (E020) E-mail

Dr. Mareike ROSCHER, Division of Radiooncology / Radiobiology (E220) E-mail

Dr. Stefan SAWALL, Division of X-Ray Imaging and Computed Tomography (E025) E-mail

Dr. Niklas WAHL, Division of Biomedical Physics in Radiation Oncology (E040) E-mail

 

Dr. Marco BINDER, Division of Virus-associated Carcinogenesis (F170) E-mail

Dr. Timo BUND, Research Group Episomal-Persistent DNA in Cancer- and Chronic Diseases (F200) E-mail

Prof. Dr. Henri-Jacques DELECLUSE, Division of Pathogenesis of Virus Associated Tumors (F100) E-mail

Dr. Susanne DELECLUSE, Division of Pathogenesis of Virus Associated Tumors (F100) E-mail

Prof. Dr. Dr. Christine ENGELAND, Clinical Cooperation Unit Virotherapy (F230) and NCT E-mail

Prof. Dr. Dirk GRIMM, CellNetworks Research Group Virus Host Interactions, Bioquant, University of Heidelberg E-Mail

Dr. Johannes HEIDBÜCHEL, Clinical Cooperation Unit Virotherapy (F230) and NCT E-mail

Prof. Dr. Mathias HEIKENWÄLDER, Division of Chronic Inflammation and Cancer (F180) E-mail

Dr. Mathias LEBER, Clinical Cooperation Unit Virotherapy (F230) and NCT E-mail

Prof. Dr. Martin LÖCHELT, Division of Viral Transformation Mechanisms (F030) E-mail

PD Dr. Antonio MARCHINI, Research Group The Laboratory of Oncolytic Virus Immuno-Therapeutics (LOVIT) (F011E-mail

Prof. Dr. Martin MÜLLER, Research Group Tumorvirus-Specific Vaccination Strategies (F035) E-mail

PD Dr. Dirk NETTELBECK, Clinical Cooperation Unit Virotherapy (F230) and NCT E-mail

Dr. Jürg NÜESCH, Division of Tumor Virology (F010) E-mail

Dr. Indrahabadur SINGH, Emmy Noether Research Group Epigenetic Machineries and Cancer, Division of Chronic Inflammation and Cancer (F180) E-mail

Dr. Christoph STEIN-THOERINGER, Division of Microbiome and Cancer (F220) E-mail

Prof. Dr. Guy UNGERECHTS, Clinical Cooperation Unit Virotherapy (F230) and NCT E-mail

Dr. Tim WATERBOER, Division of Infections and Cancer Epidemiology (F020) E-mail

How to become a Major Cancer Biology Faculty Member?

If you are DKFZ scientist or cooperative partner and wish to actively contribute to our study program by, e.g., giving lectures or tutorials, by organizing (part of) a HP-F practical, please contact the Coordinator, Prof. Ilse Hofmann, to discuss how your offer can be integrated to the program. We are always happy to welcome new active contributors!

In certain cases, teaching activities at the Bachelor level can also be honored by becoming a Major Cancer Biology faculty member.

to top
powered by webEdition CMS